It’s important to understand that autism, or Autism Spectrum Disorder (ASD), is not an illness and does not need to be “cured.” It simply means that individuals experience and interact with the world in different ways.

While traditional therapies and medications can help manage certain challenges associated with autism, medical cannabis is also legally available in the UK as an option for some individuals when conventional treatments have not been effective—a possibility that many people are still unaware of.

Cluster headache is a rare but severe condition that causes repeated, debilitating attacks of pain, often occurring at the same time each day over a period of weeks. The pain is typically intense and one-sided, affecting the area around the eye or temple, and attacks can last from as little as 15 minutes to several hours.

While first-line treatments are available to reduce pain and help prevent future episodes, they are not effective for everyone. For patients who continue to struggle despite standard therapies, medical cannabis may be an option worth exploring for managing cluster headache symptoms.

Attention Deficit Hyperactivity Disorder (ADHD) can significantly affect day-to-day life. As a neurodevelopmental and neurobehavioural condition, it usually begins in childhood and may lead to difficulties with focus, attention to detail, energy regulation, mood, and sleep.

Although there are several established treatment options for ADHD, cannabis-based medicines became legally available in the UK in 2018. For eligible patients, medical cannabis treatments for ADHD are offered by ZOTO and are growing in popularity as an alternative option.

There are more than 30 recognised epilepsy syndromes, and the condition is relatively common in the UK, affecting hundreds of thousnads of people. Epilepsy is caused by sudden bursts of electrical activity in the brain, leading to seizures. For some individuals, seizures are infrequent and well controlled with medication, while for others they can occur many times a day and remain resistant to standard treatments, with serious consequences for overall health and wellbeing.

In recent years in the UK, medical cannabis has emerged as a treatment option for people with treatment-resistant epilepsy, offering an alternative pathway when conventional therapies have not been effective.

Multiple sclerosis (MS) is a condition in which the immune system attacks the protective coating around nerve fibres, disrupting the way nerve signals are transmitted and, in some cases, damaging the nerves themselves. This can lead to symptoms such as muscle stiffness, spasms, and chronic pain.

Recent evidence suggests that medical cannabis may help alleviate some of these MS-related symptoms, and cannabis-based treatments are increasingly being explored as part of symptom management for people living with multiple sclerosis.

Neuropathic pain occurs when the nerves responsible for transmitting sensations to the brain are damaged, disrupted, or affected by an underlying health condition. While many people find relief through conventional treatments and licensed medications, these approaches are not effective for everyone.

For individuals who continue to experience symptoms despite standard care, medical cannabis and cannabis-based medicines have emerged as a popular alternative, particularly among those who have not found sufficient relief through treatments traditionally offered by the NHS.

More than 153,000 people in the UK are currently living with Parkinson’s disease, and its symptoms can have a profound impact on everyday life. Although there is still no cure, many people are able to manage symptoms with conventional, licensed treatments. However, for those who do not experience adequate relief, cannabis-based therapies are increasingly being explored as an alternative option.

While medical cannabis is not suitable for everyone, self-reported patient surveys suggest that cannabis-based treatments for Parkinson’s may help improve symptoms such as sleep disturbances, pain, tremors, and low mood, as well as contribute to better overall quality of life for some individuals.